WHO ICTRP trial

Efficacy of saraswata churna in gaming disorder

CTRI/2021/05/033896 · Clinical Trials Registry India (CTRI) · Not Recruiting

Key facts

Trial ID CTRI/2021/05/033896
Public title Efficacy of saraswata churna in gaming disorder
Scientific title Randomized controlled clinical study to evaluate the efficacy of saraswata churna in children with gaming disorder.
Primary sponsor Sri Sri College of Ayurvedic Science and Research
Registry Clinical Trials Registry India (CTRI)
Recruitment status Not Recruiting
Study type Interventional
Phase Phase 2
Countries India
Conditions Health Condition 1: F01-F99- Mental, Behavioral and Neurodevelopmental disorders
Interventions Intervention1: SARASWATA CHURNA: To be given orally for 60 days of duration, Dose according to age(13-14 years 3g BD/Day,14-15 3.25g BD/Day, 15-16 years 3.5g BD/Day) Control Intervention1: Behavioral Intervention Program: Counseling…
Registration date May 31, 2021
Target size 30
Secondary IDs NIL
Registry page ctri.nic.in

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations